AXL (P30530) variants and mutations

AXL (also known as P30530) is a human protein-coding gene encoding a tyrosine-protein kinase receptor UFO protein. Activation by GAS6 promotes cell survival, migration, immune modulation, and resistance to cellular stress. Persistent signaling is common in advanced cancers and can support epithelial-to-mesenchymal transition, metastasis, and resistance to targeted or immune therapies. This analysis covers 1,797 AXL variants and mutations. Of these, 56% have computational variant effect predictions. Disease context includes acute myeloid leukemia, neurodegenerative disease, and Alzheimer disease. Example AXL variants include M1R, A2E, and A2V.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable AXL variants

Examples include M1R, A2E, A2V, A2S, A2T, A2A, W3*, W3L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.